Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BEWI – Invitation to presentation of results for the third quarter of 2022

BEWI, a leading provider of packaging, components, and insulation solutions, will announce its results for the third quarter of 2022 on Wednesday 9 November 2022. The results will be available from 07:00 am CET at the company's homepage, www.bewi.com and Oslo Børs' news site, www.newsweb.no CEO Christian Bekken and CFO Marie Danielsson will present the results from 08:30 through a live webcast. The link to the webcast is available from BEWI’s homepage www.bewi.com/investors/reports-presentations/. It will be possible to post questions through the webcast, and a recording of the

BEWI ASA – Key information relating to dividend

At the general meeting of BEWI ASA held on 2 June 2022, the board of directors of BEWI ASA was authorised to resolve a dividend distribution of NOK 1.10 per share for the financial year of 2021. The following key dates for the dividend are resolved by the board of directors: Dividend amount: 1.10Declared currency: NOKLast day including right: 8 November 2022Ex-date: 9 November 2022Record date: 10 November 2022Payment date: On or about 18 November 2022Date of approval: 8 November 2022 For further queries, please contact: Charlotte Knudsen, Director of IR and

Diaverum launches state-of-the-art Nephrology Centre of Excellence in Romania

Diaverum, a Swedish leading global provider of renal care services, is proud to announce that it has launched a new centre dedicated to the advancement of nephrology in Romania, a first-of-its-kind initiative for the market. The Fundeni Centre of Excellence in Nephrology is expected to set a new benchmark in the treatment of chronic kidney disease (CKD) in the country, thanks to its combination of technical innovation with holistic care, underpinned by Diaverum's True care culture.Covering an area of over 4,000 m², the Centre was created with the aim to set a new standard in renal care in

Invitation to presentation of Storskogen’s interim report for the third quarter 2022

On 15 November 2022 at 07:00 (CET), Storskogen announces its interim report for the third quarter 2022. In connection with the announcement, a presentation will be held by Daniel Kaplan, CEO, and Lena Glader, CFO, followed by a Q&A session. The presentation will be held in English and start at 09:00 (CET).The presentation and the subsequent Q&A can be followed via webcast or telephone conference, with the possibility to ask questions. For participation via webcast, please use the following link: https://ir.financialhearings.com/storskogen-group-q3-2022 For participation via

Capital Markets Day 2023

HEXPOL Group is pleased to invite investors, analysts, media and other key stakeholders to its Capital Markets Day on March 20, 2023. The Capital Markets Day will be held as a physical event at our HEXPOL TPE site, in Åmål Sweden.President and CEO Georg Brunstam will, together with Peter Rosén, deputy CEO and CFO, and key members of HEXPOL Group, provide an update on HEXPOL’s strategy and growth opportunities, as well as financial development, and progress made within sustainability and selected areas. In addition, we will tour the production, and visit the new production line for

NeoDynamics hires National Sales Director for the launch of its NeoNavia® Biopsy System

NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST), a medical device company dedicated to advancing the diagnosis and care of cancer, today announced it hired Brendan Carney as National Sales Director. He will lead commercial strategy and execution, including field sales and managed markets for the company.Mr. Carney has more than 20 years of experience including Genentech and Pharmacia, leading teams and product launches in oncology, infectious diseases, endocrinology, and medical devices.  He has most recently served as Sr. Director, Market Access for Syneos Health where

Reminder: Invitation to DNB's Capital Markets Day - 15 November 2022

DNB is pleased to invite you to the Group's Capital Markets Day. Date: Tuesday 15 November 2022Time: 12:00 pm - 2:00 pm GMT. Registration and lunch from 11:00 am - 12:00 pm GMTLocation: DNB Bank ASA London Office, 8th Floor, The Walbrook Building, 25 Walbrook, London We will present an update on financial targets and strategic topics. In addition, our largest customer segments will provide a more detailed update. Speakers at the CMD will be:- Kjerstin R. Braathen, CEO- Ida Lerner, CFO- Harald Serck-Hanssen, Group EVP Corporate Banking- Ingjerd Blekeli Spiten, Group EVP

Autoliv Announces Dividend Increase

(Stockholm, Sweden, November 8, 2022) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that its quarterly dividend will be increased by 3% to 66 cents per share, from 64 cents, for the fourth quarter of 2022.“Autoliv remains committed to creating value for shareholders and the Board of Directors is pleased to approve a higher dividend payout this quarter,” says Jan Carlson, Chairman of the Board of Directors. “It is our ambition to consistently create competitive shareholder value through our purpose-led strategy and

Fellow Pankki Plc - Managers' Transactions (Pohjola)

FELLOW BANK PLC STOCK EXCHANGE RELEASE 8.11.2022 AT 2:45 PM EETPerson subject to the notification requirement Name: Markku Pohjola Position: Member of the Board/Deputy member Issuer: Fellow Bank Plc LEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATION Reference number: 20986/4/4 Transaction date: 2022-11-07 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000170915 Nature of the transaction: ACQUISITION Transaction details (1): Volume: 10000 Unit price: 0.39 EUR (2): Volume: 10000 Unit price: 0.385 EUR Aggregated

Lundbeck raises financial guidance range for the full year 2022

Valby, Denmark, November 8, 2022 - H. Lundbeck A/S (Lundbeck) announced that the financial guidance range for the full-year 2022 has been raised. Lundbeck’s revenue is driven by continued strong underlying positive momentum in the strategic brands (Abilify Maintena[®], Brintellix[®]/Trintellix[®], Rexulti[®] and Vyepti[®]). Revenue is also benefitting significantly from the appreciation of Lundbeck’s main currencies and especially the U.S. Dollar. Profitability gains due to underlying demand will be largely offset by hedging effects, normalization of promotional activity levels and

Nomination committee appointed for Cyxone Annual General Meeting 2023

Cyxone AB (publ) hereby announces that the members of the nomination committee have been appointed ahead of the 2023 AGM. The nomination committee has been appointed in accordance with the guidelines laid down at the 2022 AGMThe nomination committee shall consist of four members, one representing each of the three largest shareholders along with the chairman of the board, in accordance with the principles adopted during the annual general meeting held on Monday, May 16, 2022. The nomination committee consists of: · Ivar Nordqvist · Göran Ofsén · Bert Junno, chairman of the

NanoCap reports preliminary turnover for subsidiaries October 2022

Stockholm 2022-11-08 NanoCap Group has received preliminary sales figures from the non-listed subsidiaries for October 2022. The sales provisionally amounted to approx. SEK 6.6 million SEK (approx. SEK 2,9 million in 2021).   // This press release is a translation from the main language, which is Swedish. For more information, contact the company at: Telephone: +46 (0)8-410 59 140 ir(at)nanocapgroup.com www.nanocapgroup.com   NanoCap Group AB (publ) NanoCap invests in growth companies, primarily unlisted, as well as develops and launches its own in-house

Ecohelix secures 3,0 MEUR bridge funding to build towards full scale biopolymer production

Biotechnology scale-up company Ecohelix received new capital of 3,0 MEUR in funding round completed by end of July. Largest investors in this bridge round are Molindo Energy and Almi Invest GreenTech, who continue as anchor investors. The ownership base is also growing with the core team of employees investing in the company.Ecohelix has patented, industry scale technology to produce high performing biopolymers from pulp industry side streams. The company continues with its plan to start volume production of high performing and sustainable biopolymers at the beginning of 2025. Right now,

Truecaller has appointed Ben Zhang as Chief Business Officer

Truecaller has recruited and appointed Ben Zhang as Chief Business Officer (CBO). Ben brings an extensive growth-oriented experience both from a business and corporate development perspective. As CBO, Ben will immediately focus on and be responsible for global user growth. He will also have responsibilities on long-term revenue development initiatives and support strategic investment and partnership opportunities. Ben will join the management team of Truecaller.Prior to joining Truecaller, Ben was Director of Strategic Development team for Sequoia Capital India and Southeast Asia. As part

Securitas AB Interim Report January–September 2022

July–September 2022 · Total sales MSEK 36 013 (27 338) · Organic sales growth 7 percent (4) · Operating income before amortization MSEK 2 330 (1 605) · Operating margin 6.5 percent (5.9) · Items affecting comparability (IAC) MSEK –414 (–120), relating to the previously announced trans-formation programs and the acquisition of STANLEY Security  · Earnings per share SEK 2.46 (2.15)* · Earnings per share, before IAC, SEK 3.24 (2.34)* · Cash flow from operating activities 122 percent (75) January-September 2022 · Total sales MSEK 95 146 (79 651) · Organic

Salipro Biotech enters into collaboration and license agreement with Sanofi to advance discovery programs

The collaboration combines Salipro Biotech’s unique expertise and its Salipro[®] platform technology to stabilize a challenging drug target with Sanofi’s drug discovery programs to move forward the generation of biologics. Stockholm, Sweden, November 8, 2022 – Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration and license agreement with Sanofi on the discovery of therapeutic biologics against a challenging drug target.The collaboration brings together Salipro Biotech’s unique expertise in developing stable antigens of GPCRs, ion

EQT strengthens and diversifies its management team with key leadership appointments

EQT AB (EQT) today announced three key additions to its Executive Committee (ExCom).Suzanne Donohoe joins as Chief Commercial Officer (“CXO”) and will lead a newly-formed platform to drive EQT’s external commercial activities. She joins EQT most recently from KKR where she was a Partner & Global Head of Strategic Growth. Donohoe also built and led the Client & Partner Group for over a decade and served as Co-head of the Inclusion & Diversity Council. Her prior experience includes an extensive global career at Goldman Sachs. Altogether, Donohoe brings thirty years of experience to her new

Share subscriptions based on stock options 2018

SPINNOVA PLC, COMPANY RELEASE, 8 November 2022, 13:00 p.m. EET Share subscriptions based on stock options 2018 Between August and September 2022, a total of 17 400 Spinnova Plc’s new shares has been subscribed for with the company's stock options 2018. For subscriptions made with the stock options 2018, the entire subscription price of EUR 19 662.00 will be entered in the reserve for invested unrestricted equity. After the trade registration the total amount of shares is 51 384 845. The shares subscribed for under the stock options 2018 have been registered in the Trade Register

Correction: Eagle Filters receives orders totaling EUR 2.8 million

Loudspring Oyj Company announcement, inside information 8 November 2022 at 12:45  Correction refers to this announcement to be considered inside information and an reference has been added. As communicated in Loudsprings Q3 summary, Eagle Filters offer pipeline has had several large cases under final negotiations. Eagle Filters has now secured orders for gas turbine inlet air filters totaling EUR 2.8 million. The orders are booked into Eagle Filters’ fourth quarter 2022 order intake with deliveries planned to commence during Q4 2022 and completed during 2023. These large orders

XMReality and Nagarro sign Partnership Agreement

XMReality AB has signed a Partnership Agreement with Nagarro, a global digital engineering leader. Nagarro is actively helping their clients to work smarter through Connected Worker offerings that empower the workforce with new digital tools. This partnership will initially combine XMReality’s software with Nagarro’s Connected Maintenance Platform (CMP), which helps enterprises carry out maintenance activities and document all procedures.Sandeep Anand, Managing Director, Nagarro states, “We are excited about this partnership with XMReality that extends our Connected Worker service offerings.

First patient dosed in Annexin's Phase 2 study in retinal vein occlusion.

STOCKHOLM (8 November 2022) - Annexin Pharmaceuticals AB (publ) (Nasdaq First North Growth market) announces today that the first patient with retinal vein occlusion (RVO) has been dosed in the Company’s Phase 2 clinical study with ANXV.   RVO is one of the most common causes of blindness. Authorized drugs for treatment of RVO are injected directly into the eye and have no direct effect on the blockage of blood vessels that causes the disease. By contrast, the Company’s drug candidate ANXV, which is administered intravenously, has the potential to directly counteract the blockage of

TOMORROW IS THE LAST DAY OF THE SUBSCRIPTION PERIOD IN CESSATECH’S RIGHTS ISSUE

København, Denmark, November 8, 2022 – Cessatech A/S (“Cessatech” or the “Company”) announces that the subscription period for the Company’s rights issue of shares (the “Rights Issue” or the “Offering”) ends tomorrow. The Rights Issue is also open for subscriptions to the public.· One (1) existing share in Cessatech held on the record date of October 25, 2022, entitles to one (1) Unit Right. · Four (4) Unit Rights entitles to subscription of one (1) Unit. One (1) Unit comprise of six (6) new shares and three (3) warrants of series TO2 free of charge. · The subscription price is DKK 12

Semcon AB (publ)’s application for de-listing has been approved

Semcon AB (publ)’s (“Semcon” or the “Company”) application for de-listing has now been approved by Nasdaq Stockholm. The last day of trading in Semcon’s share on Nasdaq Stockholm will be 22 November 2022.As previously announced, Semcon has applied for de-listing of the Company’s shares from Nasdaq Stockholm. Nasdaq Stockholm has now approved the application and resolved that the last day of trading will be 22 November 2022. The information was submitted for publication, through the agency of the below listed contact person, on 8 November 2022 at 11.15 a.m. CET.

Axolot Solutions signs an agreement with Borås Energi och Miljö

Axolot Solutions has signed a rental agreement with Borås Energi och Miljö. The customer will rent a container based AxoPur[®] equipment to clean their washing water.The startup is expected to take place around year end. Initially it will be washing water that will be cleaned but going forward other waters such as contaminated leachate could come in question. The unit to be rented is the first out of Axolot’s upgraded mobile standard system, for flows between 1 and 15 m[3] /h. “The unit in Borås is the first one out of what we think might result in a number of container-based standard

There are no items matching the current filter
There are no more items matching the current filter
Back to top